条纹肌肉特定的基调编辑能够纠正导致扩张性心肌病的突变
Markus Grosch1,2,3, Laura Schraft1, Adrian Chan4
1European Molecular Biology Laboratory (EMBL), Genome Biology Unit, Heidelberg, Germany.
Nature communications
|June 22, 2023
概括
克里斯普尔基因疗法通过修复RBM20基因的突变,为遗传性扩张性心肌病提供了潜在的治疗方法. 这种新的方法在小鼠模型中成功地恢复了心脏功能,没有可检测的目标效应.
科学领域:
- 心血管医学 心血管医学
- 基因治疗 基因治疗
- 分子心脏病学分子心脏病学
背景情况:
- 扩张性心肌病是导致心力衰竭的主要原因,通常是由遗传性遗传突变驱动的.
- 目前的治疗方法有限,心脏移植是唯一确定的治疗方法.
- 克里斯普尔基因编辑具有前景,但在心脏传递和特异性方面面临挑战.
研究的目的:
- 开发和验证基于CRISPR的基因疗法,用于由RBM20突变引起的遗传扩张性心肌病.
- 评估AVMYO提供的CRISPR基编辑器在修复RBM20突变中的有效性和安全性.
主要方法:
- 利用AAVMYO病毒载体对CRISPR基编辑器的向传递到心肌细胞.
- 生成了RBM20敲入鼠标模型,作为编辑策略的体内平台.
- 采用优化的条件来实现基因修复的高效率,并评估心脏功能,基因拼接和转录资料.
主要成果:
- 在RBM20敲进小鼠模型中实现了>70%的心肌细胞修复.
- 在接受治疗的幼年小鼠中,恢复了RBM20局部化和TTN等目标的拼接.
- 观察到心脏扩张和射出分数的正常化,以及跨心脏细胞类型的转录形状的恢复.
结论:
- 通过AAVMYO提供的CRISPR基编辑器有效地修复RBM20突变,在体内引起扩展性心肌病变.
- 该策略显示了高的编辑效率,功能恢复和良好的安全概况,没有可检测的非目标突变.
- 这种方法显示出通过精确的基因修复来治疗遗传性心脏病的巨大潜力.
相关概念视频
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
17
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17
01:30Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
01:21Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
02:46Genome Copying Errors
4.3K
DNA replication is a well-evolved process that copies millions of base pairs with high fidelity during each cell division. Occasionally a wrong base or a long stretch of wrong bases may get added to the daughter strands. If the errors are left unchecked, cells might accumulate several mutations that might endanger their survival. Therefore, the copying errors are checked and repaired at three levels.
4.3K
01:29Cardiomyopathy V: Interprofessional Care
18
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
18
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12